Search

everythinglearnresearchcommunity

for

Search:↓

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Smoking worsens lipid profiles and white blood cell counts and lowers prolactin in women with PCOS.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Some women with PCOS have rare genetic variants linked to the condition.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Underweight women with PCOS can have insulin resistance, and treatment with metformin and dexamethasone can improve symptoms.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.